Advertisement

Loading...

Gratomic Inc.

CB82.FXETRA
Basic Materials
Industrial Materials
0.01
0.00(0.00%)
German Market is Open • 17:23

Gratomic Inc. Fundamental Analysis

Gratomic Inc. (CB82.F) shows weak financial fundamentals with a PE ratio of -0.85, profit margin of 0.00%, and ROE of -23.61%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.01

Areas of Concern

ROE-23.61%
Operating Margin0.00%
Cash Position1.88%
Current Ratio0.12
We analyze CB82.F's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -4.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-4.4/100

We analyze CB82.F's fundamental strength across five key dimensions:

Efficiency Score

Weak

CB82.F struggles to generate sufficient returns from assets.

ROA > 10%
-19.34%

Valuation Score

Excellent

CB82.F trades at attractive valuation levels.

PE < 25
-0.85
PEG Ratio < 2
-0.01

Growth Score

Weak

CB82.F faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

CB82.F shows balanced financial health with some risks.

Debt/Equity < 1
0.05
Current Ratio > 1
0.12

Profitability Score

Weak

CB82.F struggles to sustain strong margins.

ROE > 15%
-2361.24%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is CB82.F Expensive or Cheap?

P/E Ratio

CB82.F trades at -0.85 times earnings. This suggests potential undervaluation.

-0.85

PEG Ratio

When adjusting for growth, CB82.F's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Gratomic Inc. at 0.21 times its book value. This may indicate undervaluation.

0.21

EV/EBITDA

Enterprise value stands at -0.96 times EBITDA. This is generally considered low.

-0.96

How Well Does CB82.F Make Money?

Net Profit Margin

For every $100 in sales, Gratomic Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-23.61 in profit for every $100 of shareholder equity.

-23.61%

ROA

Gratomic Inc. generates $-19.34 in profit for every $100 in assets, demonstrating efficient asset deployment.

-19.34%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

CB82.F converts -76.75% of its market value into free cash.

-76.75%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.85

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.21

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.12

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.24

vs 25 benchmark

ROA

Return on assets percentage

-0.19

vs 25 benchmark

ROCE

Return on capital employed

-0.24

vs 25 benchmark

How CB82.F Stacks Against Its Sector Peers

MetricCB82.F ValueSector AveragePerformance
P/E Ratio-0.8523.49 Better (Cheaper)
ROE-23.61%883.00% Weak
Net Margin0.00%-94454.00% (disorted) Weak
Debt/Equity0.050.51 Strong (Low Leverage)
Current Ratio0.125.14 Weak Liquidity
ROA-19.34%-6300.00% (disorted) Weak

CB82.F outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Gratomic Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Commodity, Value

EPS CAGR

N/A

Industry Style: Cyclical, Commodity, Value

FCF CAGR

N/A

Industry Style: Cyclical, Commodity, Value

Fundamental Analysis FAQ